Aviceda Therapeutics has filed a notice of an exempt offering of securities to raise $15,610,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Aviceda Therapeutics is raising $15,610,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mohamed Genead played a key role…